Androgenic-anabolic steroids blunt morphine-induced c-fos expression in the rat striatum:: possible role of β-endorphin

被引:18
|
作者
Harlan, RE
Brown, HE
Lynch, CS
D'Souza, D
Garcia, MM
机构
[1] Tulane Univ, Sch Med, Dept Struct & Cellular Biol SL49, New Orleans, LA 70112 USA
[2] Tulane Univ, Sch Med, Dept Otolaryngol, New Orleans, LA 70112 USA
[3] Tulane Univ, Sch Med, Neurosci Program, New Orleans, LA 70112 USA
关键词
androgenic-anabolic steroid; morphine; immediate-early gene; striatum; thalamus; beta-endorphin;
D O I
10.1016/S0006-8993(99)02257-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Self-administration of large doses of androgenic-anabolic steroids (AAS) in a significant portion of the population suggests that these agents are drugs of abuse. However, acute administration of AAS did not induce striatal immediate-early genes (LEG) expression in male rats, indicating that AAS do not share a common mechanism of action with other drugs of abuse. Surveys have indicated that people who abuse AAS are more likely to self-administer other drugs of abuse than do people who do not take AAS. in the present study, chronic administration of AAS blunted the striatal c-fos response to morphine, indicating that AAS can alter the molecular responses to at least one drug of abuse. Chronic administration of AAS also increased the content of P-endorphin in the midline thalamus, suggesting a possible mechanism by which AAS may modulate the response to morphine through regulation of thalamo-striatal neurons. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 50 条
  • [41] Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure
    Chunyu Jin
    Hiroaki Araki
    Mari Nagata
    Katsuya Suemaru
    Kazuhiko Shibata
    Hiromu Kawasaki
    Takashi Hamamura
    Yutaka Gomita
    Psychopharmacology, 2004, 175 : 428 - 435
  • [42] COLONIC ABERRANT CRYPT FOCI ARE ASSOCIATED WITH INCREASED EXPRESSION OF C-FOS - THE POSSIBLE ROLE OF MODIFIED C-FOS EXPRESSION IN PRENEOPLASTIC LESIONS IN COLON CANCER
    STOPERA, SA
    DAVIE, JR
    BIRD, RP
    CARCINOGENESIS, 1992, 13 (04) : 573 - 578
  • [43] Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure
    Jin, CY
    Araki, H
    Nagata, M
    Suemaru, K
    Shibata, K
    Kawasaki, H
    Hamamura, T
    Gomita, Y
    PSYCHOPHARMACOLOGY, 2004, 175 (04) : 428 - 435
  • [44] C-FOS MEDIATES ANTIPSYCHOTIC-INDUCED NEUROTENSIN GENE-EXPRESSION IN THE RODENT STRIATUM
    ROBERTSON, GS
    TETZLAFF, W
    BEDARD, A
    STJEAN, M
    WIGLE, N
    NEUROSCIENCE, 1995, 67 (02) : 325 - 344
  • [45] Role of spinal β-endorphin on substance P release and c-FOS expression in the spinal cord dorsal horn
    Terashima, T.
    Yamaguchi, S.
    Takasusuki, T.
    Hori, Y.
    Yaksh, T.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 : 107 - 107
  • [46] Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat
    Shim, I
    Javaid, JI
    Wirtshafter, D
    Jang, SY
    Shin, KH
    Lee, HJ
    Chung, YC
    Chun, BG
    BEHAVIOURAL BRAIN RESEARCH, 2001, 121 (1-2) : 137 - 147
  • [47] Morphine- and cocaine-induced c-Fos levels in Lewis and Fischer rat strains
    Grabus, SD
    Glowa, JR
    Riley, AL
    BRAIN RESEARCH, 2004, 998 (01) : 20 - 28
  • [48] DIFFERENTIAL EXPRESSION OF C-FOS AND ZIF268 IN RAT STRIATUM AFTER HALOPERIDOL, CLOZAPINE, AND AMPHETAMINE
    NGUYEN, TV
    KOSOFSKY, BE
    BIRNBAUM, R
    COHEN, BM
    HYMAN, SE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4270 - 4274
  • [49] BASIC FIBROBLAST GROWTH-FACTOR INDUCES C-FOS EXPRESSION IN PRIMARY CULTURES OF RAT STRIATUM
    SIMPSON, CS
    MORRIS, BJ
    NEUROSCIENCE LETTERS, 1994, 170 (02) : 281 - 285
  • [50] Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat
    Honore, P
    Buritova, J
    Besson, JM
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (03) : 671 - 680